nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—SLC28A3—Gemcitabine—pancreatic cancer	0.334	1	CbGbCtD
Adenosine—Cytarabine—Gemcitabine—pancreatic cancer	0.166	0.35	CrCrCtD
Adenosine—Azacitidine—Gemcitabine—pancreatic cancer	0.158	0.333	CrCrCtD
Adenosine—Decitabine—Gemcitabine—pancreatic cancer	0.15	0.317	CrCrCtD
Adenosine—SLC28A3—islet of Langerhans—pancreatic cancer	0.0014	0.209	CbGeAlD
Adenosine—Fludarabine—SLC29A1—pancreatic cancer	0.00104	0.168	CrCbGaD
Adenosine—Ribavirin—SLC29A1—pancreatic cancer	0.00104	0.167	CrCbGaD
Adenosine—SLC28A3—pancreas—pancreatic cancer	0.000982	0.147	CbGeAlD
Adenosine—SLC28A3—digestive system—pancreatic cancer	0.000839	0.125	CbGeAlD
Adenosine—Adenosine triphosphate—HSPA1B—pancreatic cancer	0.000758	0.122	CrCbGaD
Adenosine—Adenosine triphosphate—ACVR1B—pancreatic cancer	0.000758	0.122	CrCbGaD
Adenosine—ADK—islet of Langerhans—pancreatic cancer	0.000744	0.111	CbGeAlD
Adenosine—DPP4—islet of Langerhans—pancreatic cancer	0.000721	0.108	CbGeAlD
Adenosine—Adenosine triphosphate—HSPA1A—pancreatic cancer	0.000693	0.112	CrCbGaD
Adenosine—Cytarabine—SLC29A1—pancreatic cancer	0.000671	0.108	CrCbGaD
Adenosine—ADA—digestive system—pancreatic cancer	0.000547	0.0817	CbGeAlD
Adenosine—ADK—pancreas—pancreatic cancer	0.000523	0.0781	CbGeAlD
Adenosine—DPP4—pancreas—pancreatic cancer	0.000507	0.0757	CbGeAlD
Adenosine—DPP4—digestive system—pancreatic cancer	0.000433	0.0647	CbGeAlD
Adenosine—Glucosamine—MMP9—pancreatic cancer	0.000422	0.0681	CrCbGaD
Adenosine—Glucosamine—TNF—pancreatic cancer	0.000277	0.0448	CrCbGaD
Adenosine—Adenosine triphosphate—AKT1—pancreatic cancer	0.000272	0.0438	CrCbGaD
Adenosine—Adenosine monophosphate—SRC—pancreatic cancer	0.000268	0.0432	CrCbGaD
Adenosine—Ventricular tachycardia—Epirubicin—pancreatic cancer	0.000236	0.00289	CcSEcCtD
Adenosine—Flushing—Irinotecan—pancreatic cancer	0.000236	0.00289	CcSEcCtD
Adenosine—Cardiac disorder—Irinotecan—pancreatic cancer	0.000236	0.00289	CcSEcCtD
Adenosine—Injection site reaction—Epirubicin—pancreatic cancer	0.000235	0.00287	CcSEcCtD
Adenosine—Cough—Sunitinib—pancreatic cancer	0.000234	0.00287	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000233	0.00285	CcSEcCtD
Adenosine—Convulsion—Sunitinib—pancreatic cancer	0.000233	0.00285	CcSEcCtD
Adenosine—Hypertension—Sunitinib—pancreatic cancer	0.000232	0.00284	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000231	0.00282	CcSEcCtD
Adenosine—Paraesthesia—Tamoxifen—pancreatic cancer	0.00023	0.00281	CcSEcCtD
Adenosine—Cardiac disorder—Gemcitabine—pancreatic cancer	0.00023	0.00281	CcSEcCtD
Adenosine—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000229	0.0028	CcSEcCtD
Adenosine—Chest pain—Sunitinib—pancreatic cancer	0.000229	0.0028	CcSEcCtD
Adenosine—Dyspnoea—Tamoxifen—pancreatic cancer	0.000228	0.00279	CcSEcCtD
Adenosine—Arrhythmia—Irinotecan—pancreatic cancer	0.000227	0.00278	CcSEcCtD
Adenosine—Dyspnoea—Erlotinib—pancreatic cancer	0.000226	0.00276	CcSEcCtD
Adenosine—Atrioventricular block—Doxorubicin—pancreatic cancer	0.000225	0.00275	CcSEcCtD
Adenosine—Dry mouth—Sunitinib—pancreatic cancer	0.000224	0.00274	CcSEcCtD
Adenosine—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.000223	0.00273	CcSEcCtD
Adenosine—Arrhythmia—Gemcitabine—pancreatic cancer	0.000221	0.00271	CcSEcCtD
Adenosine—Pain—Tamoxifen—pancreatic cancer	0.000219	0.00268	CcSEcCtD
Adenosine—Ventricular tachycardia—Doxorubicin—pancreatic cancer	0.000218	0.00267	CcSEcCtD
Adenosine—Arrhythmia—Fluorouracil—pancreatic cancer	0.000217	0.00266	CcSEcCtD
Adenosine—Injection site reaction—Doxorubicin—pancreatic cancer	0.000217	0.00266	CcSEcCtD
Adenosine—Pain—Erlotinib—pancreatic cancer	0.000216	0.00265	CcSEcCtD
Adenosine—Bronchospasm—Docetaxel—pancreatic cancer	0.000216	0.00264	CcSEcCtD
Adenosine—Shock—Sunitinib—pancreatic cancer	0.000216	0.00264	CcSEcCtD
Adenosine—Back pain—Irinotecan—pancreatic cancer	0.000214	0.00262	CcSEcCtD
Adenosine—Back pain—Gemcitabine—pancreatic cancer	0.000208	0.00255	CcSEcCtD
Adenosine—Urticaria—Tamoxifen—pancreatic cancer	0.000203	0.00249	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.0002	0.00244	CcSEcCtD
Adenosine—Vision blurred—Fluorouracil—pancreatic cancer	0.0002	0.00244	CcSEcCtD
Adenosine—Syncope—Irinotecan—pancreatic cancer	0.000198	0.00243	CcSEcCtD
Adenosine—Paraesthesia—Sunitinib—pancreatic cancer	0.000197	0.00241	CcSEcCtD
Adenosine—Dyspnoea—Sunitinib—pancreatic cancer	0.000195	0.00239	CcSEcCtD
Adenosine—Loss of consciousness—Irinotecan—pancreatic cancer	0.000194	0.00238	CcSEcCtD
Adenosine—Cough—Irinotecan—pancreatic cancer	0.000193	0.00236	CcSEcCtD
Adenosine—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.000193	0.00236	CcSEcCtD
Adenosine—Myocardial infarction—Docetaxel—pancreatic cancer	0.000192	0.00235	CcSEcCtD
Adenosine—Hypertension—Irinotecan—pancreatic cancer	0.000191	0.00234	CcSEcCtD
Adenosine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000189	0.00231	CcSEcCtD
Adenosine—Cough—Gemcitabine—pancreatic cancer	0.000188	0.0023	CcSEcCtD
Adenosine—Pain—Sunitinib—pancreatic cancer	0.000187	0.00229	CcSEcCtD
Adenosine—Discomfort—Irinotecan—pancreatic cancer	0.000186	0.00228	CcSEcCtD
Adenosine—Hypertension—Gemcitabine—pancreatic cancer	0.000186	0.00228	CcSEcCtD
Adenosine—Asthenia—Tamoxifen—pancreatic cancer	0.000184	0.00225	CcSEcCtD
Adenosine—Convulsion—Fluorouracil—pancreatic cancer	0.000184	0.00225	CcSEcCtD
Adenosine—Chest pain—Gemcitabine—pancreatic cancer	0.000183	0.00224	CcSEcCtD
Adenosine—Asthenia—Erlotinib—pancreatic cancer	0.000182	0.00222	CcSEcCtD
Adenosine—Discomfort—Gemcitabine—pancreatic cancer	0.000181	0.00222	CcSEcCtD
Adenosine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000181	0.00221	CcSEcCtD
Adenosine—Chest pain—Fluorouracil—pancreatic cancer	0.00018	0.00221	CcSEcCtD
Adenosine—Discomfort—Fluorouracil—pancreatic cancer	0.000178	0.00218	CcSEcCtD
Adenosine—Shock—Irinotecan—pancreatic cancer	0.000178	0.00217	CcSEcCtD
Adenosine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000176	0.00215	CcSEcCtD
Adenosine—Cardiac failure—Epirubicin—pancreatic cancer	0.000175	0.00215	CcSEcCtD
Adenosine—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000175	0.00214	CcSEcCtD
Adenosine—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.000175	0.00214	CcSEcCtD
Adenosine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000175	0.00214	CcSEcCtD
Adenosine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000173	0.00212	CcSEcCtD
Adenosine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00017	0.00208	CcSEcCtD
Adenosine—Dizziness—Tamoxifen—pancreatic cancer	0.000169	0.00207	CcSEcCtD
Adenosine—Tachycardia—Fluorouracil—pancreatic cancer	0.000169	0.00206	CcSEcCtD
Adenosine—Hypotension—Irinotecan—pancreatic cancer	0.000169	0.00206	CcSEcCtD
Adenosine—Affect lability—Epirubicin—pancreatic cancer	0.000169	0.00206	CcSEcCtD
Adenosine—Dizziness—Erlotinib—pancreatic cancer	0.000167	0.00205	CcSEcCtD
Adenosine—Hypotension—Gemcitabine—pancreatic cancer	0.000164	0.00201	CcSEcCtD
Adenosine—Flushing—Docetaxel—pancreatic cancer	0.000163	0.00199	CcSEcCtD
Adenosine—Cardiac disorder—Docetaxel—pancreatic cancer	0.000163	0.00199	CcSEcCtD
Adenosine—Cardiac arrest—Epirubicin—pancreatic cancer	0.000163	0.00199	CcSEcCtD
Adenosine—Vomiting—Tamoxifen—pancreatic cancer	0.000163	0.00199	CcSEcCtD
Adenosine—Cardiac failure—Doxorubicin—pancreatic cancer	0.000162	0.00199	CcSEcCtD
Adenosine—Mood swings—Epirubicin—pancreatic cancer	0.000162	0.00198	CcSEcCtD
Adenosine—Paraesthesia—Irinotecan—pancreatic cancer	0.000162	0.00198	CcSEcCtD
Adenosine—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000162	0.00198	CcSEcCtD
Adenosine—Hypotension—Fluorouracil—pancreatic cancer	0.000162	0.00198	CcSEcCtD
Adenosine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000161	0.00198	CcSEcCtD
Adenosine—Rash—Tamoxifen—pancreatic cancer	0.000161	0.00197	CcSEcCtD
Adenosine—Dermatitis—Tamoxifen—pancreatic cancer	0.000161	0.00197	CcSEcCtD
Adenosine—Vomiting—Erlotinib—pancreatic cancer	0.000161	0.00197	CcSEcCtD
Adenosine—Dyspnoea—Irinotecan—pancreatic cancer	0.000161	0.00197	CcSEcCtD
Adenosine—Somnolence—Irinotecan—pancreatic cancer	0.00016	0.00196	CcSEcCtD
Adenosine—Headache—Tamoxifen—pancreatic cancer	0.00016	0.00196	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00016	0.00196	CcSEcCtD
Adenosine—Rash—Erlotinib—pancreatic cancer	0.00016	0.00195	CcSEcCtD
Adenosine—Dermatitis—Erlotinib—pancreatic cancer	0.000159	0.00195	CcSEcCtD
Adenosine—Headache—Erlotinib—pancreatic cancer	0.000159	0.00194	CcSEcCtD
Adenosine—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000158	0.00194	CcSEcCtD
Adenosine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000158	0.00193	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000158	0.00193	CcSEcCtD
Adenosine—Asthenia—Sunitinib—pancreatic cancer	0.000157	0.00192	CcSEcCtD
Adenosine—Arrhythmia—Docetaxel—pancreatic cancer	0.000157	0.00192	CcSEcCtD
Adenosine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000157	0.00192	CcSEcCtD
Adenosine—Somnolence—Gemcitabine—pancreatic cancer	0.000156	0.00191	CcSEcCtD
Adenosine—Affect lability—Doxorubicin—pancreatic cancer	0.000156	0.00191	CcSEcCtD
Adenosine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000155	0.0019	CcSEcCtD
Adenosine—Pain—Irinotecan—pancreatic cancer	0.000154	0.00189	CcSEcCtD
Adenosine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000154	0.00189	CcSEcCtD
Adenosine—Somnolence—Fluorouracil—pancreatic cancer	0.000154	0.00188	CcSEcCtD
Adenosine—Nausea—Tamoxifen—pancreatic cancer	0.000152	0.00186	CcSEcCtD
Adenosine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000151	0.00184	CcSEcCtD
Adenosine—Pain—Gemcitabine—pancreatic cancer	0.00015	0.00184	CcSEcCtD
Adenosine—Nausea—Erlotinib—pancreatic cancer	0.00015	0.00184	CcSEcCtD
Adenosine—Mood swings—Doxorubicin—pancreatic cancer	0.00015	0.00184	CcSEcCtD
Adenosine—Dysgeusia—Docetaxel—pancreatic cancer	0.00015	0.00183	CcSEcCtD
Adenosine—Back pain—Docetaxel—pancreatic cancer	0.000148	0.00181	CcSEcCtD
Adenosine—Pain—Fluorouracil—pancreatic cancer	0.000148	0.00181	CcSEcCtD
Adenosine—Dizziness—Sunitinib—pancreatic cancer	0.000145	0.00177	CcSEcCtD
Adenosine—Vomiting—Sunitinib—pancreatic cancer	0.000139	0.0017	CcSEcCtD
Adenosine—Rash—Sunitinib—pancreatic cancer	0.000138	0.00169	CcSEcCtD
Adenosine—Dermatitis—Sunitinib—pancreatic cancer	0.000138	0.00169	CcSEcCtD
Adenosine—Urticaria—Fluorouracil—pancreatic cancer	0.000137	0.00168	CcSEcCtD
Adenosine—Headache—Sunitinib—pancreatic cancer	0.000137	0.00168	CcSEcCtD
Adenosine—Syncope—Docetaxel—pancreatic cancer	0.000137	0.00168	CcSEcCtD
Adenosine—Pollakiuria—Epirubicin—pancreatic cancer	0.000137	0.00167	CcSEcCtD
Adenosine—Palpitations—Docetaxel—pancreatic cancer	0.000135	0.00165	CcSEcCtD
Adenosine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000134	0.00164	CcSEcCtD
Adenosine—Cough—Docetaxel—pancreatic cancer	0.000133	0.00163	CcSEcCtD
Adenosine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000133	0.00163	CcSEcCtD
Adenosine—Convulsion—Docetaxel—pancreatic cancer	0.000132	0.00162	CcSEcCtD
Adenosine—Hypertension—Docetaxel—pancreatic cancer	0.000132	0.00162	CcSEcCtD
Adenosine—Drowsiness—Epirubicin—pancreatic cancer	0.000132	0.00161	CcSEcCtD
Adenosine—Chest pain—Docetaxel—pancreatic cancer	0.00013	0.00159	CcSEcCtD
Adenosine—Nausea—Sunitinib—pancreatic cancer	0.00013	0.00159	CcSEcCtD
Adenosine—Asthenia—Irinotecan—pancreatic cancer	0.00013	0.00158	CcSEcCtD
Adenosine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000127	0.00156	CcSEcCtD
Adenosine—Dry mouth—Docetaxel—pancreatic cancer	0.000127	0.00156	CcSEcCtD
Adenosine—Sweating—Epirubicin—pancreatic cancer	0.000127	0.00155	CcSEcCtD
Adenosine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000127	0.00155	CcSEcCtD
Adenosine—Asthenia—Gemcitabine—pancreatic cancer	0.000126	0.00154	CcSEcCtD
Adenosine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000125	0.00153	CcSEcCtD
Adenosine—Shock—Docetaxel—pancreatic cancer	0.000123	0.0015	CcSEcCtD
Adenosine—Drowsiness—Doxorubicin—pancreatic cancer	0.000122	0.00149	CcSEcCtD
Adenosine—Tachycardia—Docetaxel—pancreatic cancer	0.000122	0.00149	CcSEcCtD
Adenosine—Bradycardia—Epirubicin—pancreatic cancer	0.000121	0.00148	CcSEcCtD
Adenosine—Dizziness—Irinotecan—pancreatic cancer	0.000119	0.00146	CcSEcCtD
Adenosine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000118	0.00144	CcSEcCtD
Adenosine—Sweating—Doxorubicin—pancreatic cancer	0.000117	0.00143	CcSEcCtD
Adenosine—Hypotension—Docetaxel—pancreatic cancer	0.000117	0.00143	CcSEcCtD
Adenosine—Vomiting—Irinotecan—pancreatic cancer	0.000115	0.0014	CcSEcCtD
Adenosine—Dizziness—Fluorouracil—pancreatic cancer	0.000114	0.0014	CcSEcCtD
Adenosine—Rash—Irinotecan—pancreatic cancer	0.000114	0.00139	CcSEcCtD
Adenosine—Dermatitis—Irinotecan—pancreatic cancer	0.000114	0.00139	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000114	0.00139	CcSEcCtD
Adenosine—Headache—Irinotecan—pancreatic cancer	0.000113	0.00138	CcSEcCtD
Adenosine—Paraesthesia—Docetaxel—pancreatic cancer	0.000112	0.00137	CcSEcCtD
Adenosine—Vomiting—Gemcitabine—pancreatic cancer	0.000112	0.00137	CcSEcCtD
Adenosine—Bradycardia—Doxorubicin—pancreatic cancer	0.000112	0.00137	CcSEcCtD
Adenosine—Dyspnoea—Docetaxel—pancreatic cancer	0.000111	0.00136	CcSEcCtD
Adenosine—Somnolence—Docetaxel—pancreatic cancer	0.000111	0.00136	CcSEcCtD
Adenosine—Rash—Gemcitabine—pancreatic cancer	0.000111	0.00136	CcSEcCtD
Adenosine—Dermatitis—Gemcitabine—pancreatic cancer	0.000111	0.00136	CcSEcCtD
Adenosine—Tinnitus—Epirubicin—pancreatic cancer	0.00011	0.00135	CcSEcCtD
Adenosine—Headache—Gemcitabine—pancreatic cancer	0.00011	0.00135	CcSEcCtD
Adenosine—Cardiac disorder—Epirubicin—pancreatic cancer	0.00011	0.00135	CcSEcCtD
Adenosine—Flushing—Epirubicin—pancreatic cancer	0.00011	0.00135	CcSEcCtD
Adenosine—Vomiting—Fluorouracil—pancreatic cancer	0.00011	0.00135	CcSEcCtD
Adenosine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000109	0.00133	CcSEcCtD
Adenosine—Rash—Fluorouracil—pancreatic cancer	0.000109	0.00133	CcSEcCtD
Adenosine—Dermatitis—Fluorouracil—pancreatic cancer	0.000109	0.00133	CcSEcCtD
Adenosine—Headache—Fluorouracil—pancreatic cancer	0.000108	0.00133	CcSEcCtD
Adenosine—Nausea—Irinotecan—pancreatic cancer	0.000107	0.00131	CcSEcCtD
Adenosine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000107	0.00131	CcSEcCtD
Adenosine—Pain—Docetaxel—pancreatic cancer	0.000107	0.00131	CcSEcCtD
Adenosine—Arrhythmia—Epirubicin—pancreatic cancer	0.000106	0.00129	CcSEcCtD
Adenosine—Nausea—Gemcitabine—pancreatic cancer	0.000104	0.00128	CcSEcCtD
Adenosine—Nausea—Fluorouracil—pancreatic cancer	0.000103	0.00126	CcSEcCtD
Adenosine—Tinnitus—Doxorubicin—pancreatic cancer	0.000102	0.00125	CcSEcCtD
Adenosine—Flushing—Doxorubicin—pancreatic cancer	0.000102	0.00124	CcSEcCtD
Adenosine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000102	0.00124	CcSEcCtD
Adenosine—Tension—Epirubicin—pancreatic cancer	0.000101	0.00124	CcSEcCtD
Adenosine—Dysgeusia—Epirubicin—pancreatic cancer	0.000101	0.00124	CcSEcCtD
Adenosine—Nervousness—Epirubicin—pancreatic cancer	0.0001	0.00123	CcSEcCtD
Adenosine—Back pain—Epirubicin—pancreatic cancer	9.98e-05	0.00122	CcSEcCtD
Adenosine—Mediastinal disorder—Doxorubicin—pancreatic cancer	9.88e-05	0.00121	CcSEcCtD
Adenosine—Arrhythmia—Doxorubicin—pancreatic cancer	9.79e-05	0.0012	CcSEcCtD
Adenosine—Vision blurred—Epirubicin—pancreatic cancer	9.72e-05	0.00119	CcSEcCtD
Adenosine—Agitation—Epirubicin—pancreatic cancer	9.48e-05	0.00116	CcSEcCtD
Adenosine—Tension—Doxorubicin—pancreatic cancer	9.36e-05	0.00115	CcSEcCtD
Adenosine—Dysgeusia—Doxorubicin—pancreatic cancer	9.34e-05	0.00114	CcSEcCtD
Adenosine—Nervousness—Doxorubicin—pancreatic cancer	9.27e-05	0.00113	CcSEcCtD
Adenosine—Syncope—Epirubicin—pancreatic cancer	9.25e-05	0.00113	CcSEcCtD
Adenosine—Back pain—Doxorubicin—pancreatic cancer	9.23e-05	0.00113	CcSEcCtD
Adenosine—Hypersensitivity—Docetaxel—pancreatic cancer	9.19e-05	0.00112	CcSEcCtD
Adenosine—Palpitations—Epirubicin—pancreatic cancer	9.11e-05	0.00112	CcSEcCtD
Adenosine—Loss of consciousness—Epirubicin—pancreatic cancer	9.06e-05	0.00111	CcSEcCtD
Adenosine—Cough—Epirubicin—pancreatic cancer	9e-05	0.0011	CcSEcCtD
Adenosine—Vision blurred—Doxorubicin—pancreatic cancer	8.99e-05	0.0011	CcSEcCtD
Adenosine—Asthenia—Docetaxel—pancreatic cancer	8.95e-05	0.0011	CcSEcCtD
Adenosine—Convulsion—Epirubicin—pancreatic cancer	8.94e-05	0.00109	CcSEcCtD
Adenosine—Hypertension—Epirubicin—pancreatic cancer	8.9e-05	0.00109	CcSEcCtD
Adenosine—Chest pain—Epirubicin—pancreatic cancer	8.78e-05	0.00107	CcSEcCtD
Adenosine—Agitation—Doxorubicin—pancreatic cancer	8.77e-05	0.00107	CcSEcCtD
Adenosine—Anxiety—Epirubicin—pancreatic cancer	8.75e-05	0.00107	CcSEcCtD
Adenosine—Discomfort—Epirubicin—pancreatic cancer	8.68e-05	0.00106	CcSEcCtD
Adenosine—Dry mouth—Epirubicin—pancreatic cancer	8.59e-05	0.00105	CcSEcCtD
Adenosine—Syncope—Doxorubicin—pancreatic cancer	8.56e-05	0.00105	CcSEcCtD
Adenosine—Palpitations—Doxorubicin—pancreatic cancer	8.43e-05	0.00103	CcSEcCtD
Adenosine—Anaphylactic shock—Epirubicin—pancreatic cancer	8.42e-05	0.00103	CcSEcCtD
Adenosine—Loss of consciousness—Doxorubicin—pancreatic cancer	8.39e-05	0.00103	CcSEcCtD
Adenosine—Cough—Doxorubicin—pancreatic cancer	8.33e-05	0.00102	CcSEcCtD
Adenosine—Shock—Epirubicin—pancreatic cancer	8.28e-05	0.00101	CcSEcCtD
Adenosine—Convulsion—Doxorubicin—pancreatic cancer	8.27e-05	0.00101	CcSEcCtD
Adenosine—Dizziness—Docetaxel—pancreatic cancer	8.25e-05	0.00101	CcSEcCtD
Adenosine—Hypertension—Doxorubicin—pancreatic cancer	8.24e-05	0.00101	CcSEcCtD
Adenosine—Tachycardia—Epirubicin—pancreatic cancer	8.21e-05	0.00101	CcSEcCtD
Adenosine—Hyperhidrosis—Epirubicin—pancreatic cancer	8.14e-05	0.000996	CcSEcCtD
Adenosine—Chest pain—Doxorubicin—pancreatic cancer	8.12e-05	0.000994	CcSEcCtD
Adenosine—Anxiety—Doxorubicin—pancreatic cancer	8.1e-05	0.000991	CcSEcCtD
Adenosine—Discomfort—Doxorubicin—pancreatic cancer	8.03e-05	0.000982	CcSEcCtD
Adenosine—Dry mouth—Doxorubicin—pancreatic cancer	7.95e-05	0.000972	CcSEcCtD
Adenosine—Vomiting—Docetaxel—pancreatic cancer	7.93e-05	0.000971	CcSEcCtD
Adenosine—Rash—Docetaxel—pancreatic cancer	7.87e-05	0.000963	CcSEcCtD
Adenosine—Hypotension—Epirubicin—pancreatic cancer	7.87e-05	0.000962	CcSEcCtD
Adenosine—Dermatitis—Docetaxel—pancreatic cancer	7.86e-05	0.000962	CcSEcCtD
Adenosine—Headache—Docetaxel—pancreatic cancer	7.82e-05	0.000957	CcSEcCtD
Adenosine—Anaphylactic shock—Doxorubicin—pancreatic cancer	7.79e-05	0.000953	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.67e-05	0.000938	CcSEcCtD
Adenosine—Shock—Doxorubicin—pancreatic cancer	7.66e-05	0.000937	CcSEcCtD
Adenosine—Tachycardia—Doxorubicin—pancreatic cancer	7.6e-05	0.00093	CcSEcCtD
Adenosine—Paraesthesia—Epirubicin—pancreatic cancer	7.56e-05	0.000925	CcSEcCtD
Adenosine—Hyperhidrosis—Doxorubicin—pancreatic cancer	7.53e-05	0.000921	CcSEcCtD
Adenosine—Dyspnoea—Epirubicin—pancreatic cancer	7.5e-05	0.000918	CcSEcCtD
Adenosine—Somnolence—Epirubicin—pancreatic cancer	7.48e-05	0.000916	CcSEcCtD
Adenosine—Nausea—Docetaxel—pancreatic cancer	7.41e-05	0.000907	CcSEcCtD
Adenosine—Hypotension—Doxorubicin—pancreatic cancer	7.28e-05	0.00089	CcSEcCtD
Adenosine—Pain—Epirubicin—pancreatic cancer	7.2e-05	0.000881	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.1e-05	0.000868	CcSEcCtD
Adenosine—Paraesthesia—Doxorubicin—pancreatic cancer	6.99e-05	0.000856	CcSEcCtD
Adenosine—Dyspnoea—Doxorubicin—pancreatic cancer	6.94e-05	0.00085	CcSEcCtD
Adenosine—Somnolence—Doxorubicin—pancreatic cancer	6.92e-05	0.000847	CcSEcCtD
Adenosine—Urticaria—Epirubicin—pancreatic cancer	6.69e-05	0.000818	CcSEcCtD
Adenosine—Pain—Doxorubicin—pancreatic cancer	6.66e-05	0.000815	CcSEcCtD
Adenosine—Hypersensitivity—Epirubicin—pancreatic cancer	6.2e-05	0.000759	CcSEcCtD
Adenosine—Urticaria—Doxorubicin—pancreatic cancer	6.19e-05	0.000757	CcSEcCtD
Adenosine—Asthenia—Epirubicin—pancreatic cancer	6.04e-05	0.000739	CcSEcCtD
Adenosine—Hypersensitivity—Doxorubicin—pancreatic cancer	5.74e-05	0.000702	CcSEcCtD
Adenosine—Asthenia—Doxorubicin—pancreatic cancer	5.59e-05	0.000684	CcSEcCtD
Adenosine—Dizziness—Epirubicin—pancreatic cancer	5.57e-05	0.000681	CcSEcCtD
Adenosine—Vomiting—Epirubicin—pancreatic cancer	5.35e-05	0.000655	CcSEcCtD
Adenosine—Rash—Epirubicin—pancreatic cancer	5.31e-05	0.000649	CcSEcCtD
Adenosine—Dermatitis—Epirubicin—pancreatic cancer	5.3e-05	0.000649	CcSEcCtD
Adenosine—Headache—Epirubicin—pancreatic cancer	5.27e-05	0.000645	CcSEcCtD
Adenosine—Dizziness—Doxorubicin—pancreatic cancer	5.15e-05	0.00063	CcSEcCtD
Adenosine—Nausea—Epirubicin—pancreatic cancer	5e-05	0.000612	CcSEcCtD
Adenosine—Vomiting—Doxorubicin—pancreatic cancer	4.95e-05	0.000606	CcSEcCtD
Adenosine—Rash—Doxorubicin—pancreatic cancer	4.91e-05	0.000601	CcSEcCtD
Adenosine—Dermatitis—Doxorubicin—pancreatic cancer	4.91e-05	0.0006	CcSEcCtD
Adenosine—Headache—Doxorubicin—pancreatic cancer	4.88e-05	0.000597	CcSEcCtD
Adenosine—Nausea—Doxorubicin—pancreatic cancer	4.63e-05	0.000566	CcSEcCtD
Adenosine—ADORA2A—Signaling Pathways—SSTR1—pancreatic cancer	3.86e-05	0.000401	CbGpPWpGaD
Adenosine—ADK—Metabolism—APOE—pancreatic cancer	3.8e-05	0.000395	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SCT—pancreatic cancer	3.79e-05	0.000394	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HEY1—pancreatic cancer	3.79e-05	0.000394	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PPY—pancreatic cancer	3.79e-05	0.000393	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SHH—pancreatic cancer	3.72e-05	0.000386	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SSTR2—pancreatic cancer	3.72e-05	0.000386	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NOTCH4—pancreatic cancer	3.69e-05	0.000384	CbGpPWpGaD
Adenosine—ADA—Metabolism—STK11—pancreatic cancer	3.69e-05	0.000383	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—CTNNB1—pancreatic cancer	3.69e-05	0.000383	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—CASP3—pancreatic cancer	3.67e-05	0.000381	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IAPP—pancreatic cancer	3.67e-05	0.000381	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—pancreatic cancer	3.65e-05	0.000379	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CNR1—pancreatic cancer	3.64e-05	0.000378	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCK—pancreatic cancer	3.62e-05	0.000375	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCKBR—pancreatic cancer	3.59e-05	0.000373	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—SST—pancreatic cancer	3.58e-05	0.000372	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	3.57e-05	0.000371	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTHLH—pancreatic cancer	3.52e-05	0.000366	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTCH1—pancreatic cancer	3.52e-05	0.000366	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GLP1R—pancreatic cancer	3.52e-05	0.000366	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CNR2—pancreatic cancer	3.52e-05	0.000366	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CXCL8—pancreatic cancer	3.52e-05	0.000366	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—GCG—pancreatic cancer	3.52e-05	0.000365	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCKAR—pancreatic cancer	3.47e-05	0.00036	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PTEN—pancreatic cancer	3.45e-05	0.000358	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—pancreatic cancer	3.45e-05	0.000358	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CG—pancreatic cancer	3.43e-05	0.000356	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GLI1—pancreatic cancer	3.38e-05	0.00035	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—DTX4—pancreatic cancer	3.38e-05	0.00035	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—JAG2—pancreatic cancer	3.36e-05	0.000349	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AGTR1—pancreatic cancer	3.35e-05	0.000348	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MEN1—pancreatic cancer	3.31e-05	0.000344	CbGpPWpGaD
Adenosine—ADK—Metabolism—PPARG—pancreatic cancer	3.31e-05	0.000344	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CNR1—pancreatic cancer	3.31e-05	0.000343	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PPP2R5B—pancreatic cancer	3.28e-05	0.000341	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NRP1—pancreatic cancer	3.28e-05	0.000341	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SST—pancreatic cancer	3.22e-05	0.000335	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—SRC—pancreatic cancer	3.2e-05	0.000332	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—GCG—pancreatic cancer	3.19e-05	0.000331	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.18e-05	0.00033	CbGpPWpGaD
Adenosine—ADA—Metabolism—TYMS—pancreatic cancer	3.18e-05	0.00033	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PIK3CA—pancreatic cancer	3.17e-05	0.000329	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SHH—pancreatic cancer	3.16e-05	0.000328	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HEY2—pancreatic cancer	3.16e-05	0.000328	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—JAG1—pancreatic cancer	3.15e-05	0.000327	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NOTCH3—pancreatic cancer	3.14e-05	0.000326	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NOTCH4—pancreatic cancer	3.14e-05	0.000326	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—TP53—pancreatic cancer	3.12e-05	0.000324	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IAPP—pancreatic cancer	3.12e-05	0.000324	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GAST—pancreatic cancer	3.09e-05	0.000321	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—STAT3—pancreatic cancer	3.09e-05	0.00032	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—NRAS—pancreatic cancer	3.08e-05	0.00032	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AGTR1—pancreatic cancer	3.05e-05	0.000316	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CD—pancreatic cancer	3.02e-05	0.000313	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTHLH—pancreatic cancer	3e-05	0.000311	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTCH1—pancreatic cancer	3e-05	0.000311	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CNR1—pancreatic cancer	2.97e-05	0.000309	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—pancreatic cancer	2.93e-05	0.000304	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SCT—pancreatic cancer	2.93e-05	0.000304	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HEY1—pancreatic cancer	2.93e-05	0.000304	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CG—pancreatic cancer	2.89e-05	0.0003	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—GCG—pancreatic cancer	2.87e-05	0.000298	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—EGFR—pancreatic cancer	2.81e-05	0.000291	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.79e-05	0.00029	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCK—pancreatic cancer	2.79e-05	0.00029	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AGTR1—pancreatic cancer	2.74e-05	0.000285	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SST—pancreatic cancer	2.74e-05	0.000285	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CNR2—pancreatic cancer	2.72e-05	0.000283	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GLP1R—pancreatic cancer	2.72e-05	0.000283	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CXCL8—pancreatic cancer	2.72e-05	0.000282	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.7e-05	0.000281	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—STK11—pancreatic cancer	2.7e-05	0.00028	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—JAG1—pancreatic cancer	2.68e-05	0.000278	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCKAR—pancreatic cancer	2.68e-05	0.000278	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NOTCH3—pancreatic cancer	2.67e-05	0.000277	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—KRAS—pancreatic cancer	2.65e-05	0.000275	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CB—pancreatic cancer	2.63e-05	0.000273	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTGS2—pancreatic cancer	2.6e-05	0.00027	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—JAG2—pancreatic cancer	2.6e-05	0.00027	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—pancreatic cancer	2.59e-05	0.000269	CbGpPWpGaD
Adenosine—ADA—Metabolism—APOE—pancreatic cancer	2.58e-05	0.000268	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MEN1—pancreatic cancer	2.56e-05	0.000266	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CD—pancreatic cancer	2.54e-05	0.000263	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CNR1—pancreatic cancer	2.53e-05	0.000263	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CG—pancreatic cancer	2.45e-05	0.000255	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GCG—pancreatic cancer	2.44e-05	0.000254	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SHH—pancreatic cancer	2.44e-05	0.000253	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.44e-05	0.000253	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PIK3CA—pancreatic cancer	2.43e-05	0.000253	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOTCH4—pancreatic cancer	2.43e-05	0.000252	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IAPP—pancreatic cancer	2.41e-05	0.00025	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.38e-05	0.000247	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SMAD4—pancreatic cancer	2.37e-05	0.000246	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CXCL8—pancreatic cancer	2.34e-05	0.000243	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CG—pancreatic cancer	2.33e-05	0.000242	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AGTR1—pancreatic cancer	2.33e-05	0.000242	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTHLH—pancreatic cancer	2.31e-05	0.00024	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTCH1—pancreatic cancer	2.31e-05	0.00024	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HES1—pancreatic cancer	2.31e-05	0.00024	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—STK11—pancreatic cancer	2.3e-05	0.000238	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTEN—pancreatic cancer	2.27e-05	0.000236	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—HRAS—pancreatic cancer	2.25e-05	0.000234	CbGpPWpGaD
Adenosine—ADA—Metabolism—PPARG—pancreatic cancer	2.25e-05	0.000234	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CB—pancreatic cancer	2.21e-05	0.00023	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.16e-05	0.000224	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CXCL8—pancreatic cancer	2.13e-05	0.000221	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SST—pancreatic cancer	2.12e-05	0.00022	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.09e-05	0.000217	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.07e-05	0.000215	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—JAG1—pancreatic cancer	2.07e-05	0.000215	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOTCH3—pancreatic cancer	2.06e-05	0.000214	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CD—pancreatic cancer	2.05e-05	0.000213	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TERT—pancreatic cancer	2.02e-05	0.00021	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SMAD4—pancreatic cancer	2.01e-05	0.000209	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.99e-05	0.000207	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—AKT1—pancreatic cancer	1.99e-05	0.000207	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HES1—pancreatic cancer	1.96e-05	0.000204	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CNR1—pancreatic cancer	1.95e-05	0.000203	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HIF1A—pancreatic cancer	1.94e-05	0.000201	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TSC2—pancreatic cancer	1.93e-05	0.0002	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CG—pancreatic cancer	1.9e-05	0.000197	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APOE—pancreatic cancer	1.89e-05	0.000196	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GCG—pancreatic cancer	1.89e-05	0.000196	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.88e-05	0.000195	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KDR—pancreatic cancer	1.85e-05	0.000192	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.83e-05	0.00019	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCL8—pancreatic cancer	1.81e-05	0.000188	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AGTR1—pancreatic cancer	1.8e-05	0.000187	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CB—pancreatic cancer	1.79e-05	0.000185	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—STK11—pancreatic cancer	1.77e-05	0.000184	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTGS2—pancreatic cancer	1.77e-05	0.000184	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NFKBIA—pancreatic cancer	1.76e-05	0.000183	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NOTCH1—pancreatic cancer	1.74e-05	0.000181	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TERT—pancreatic cancer	1.72e-05	0.000179	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CG—pancreatic cancer	1.71e-05	0.000177	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—NRAS—pancreatic cancer	1.71e-05	0.000177	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EGF—pancreatic cancer	1.69e-05	0.000175	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CD—pancreatic cancer	1.67e-05	0.000173	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HIF1A—pancreatic cancer	1.65e-05	0.000171	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TSC2—pancreatic cancer	1.64e-05	0.00017	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APOE—pancreatic cancer	1.61e-05	0.000167	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CA—pancreatic cancer	1.6e-05	0.000166	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.6e-05	0.000166	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KDR—pancreatic cancer	1.57e-05	0.000163	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—EGFR—pancreatic cancer	1.55e-05	0.000161	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SMAD4—pancreatic cancer	1.55e-05	0.000161	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTEN—pancreatic cancer	1.54e-05	0.00016	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCL8—pancreatic cancer	1.54e-05	0.00016	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HES1—pancreatic cancer	1.52e-05	0.000157	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CD—pancreatic cancer	1.5e-05	0.000156	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NFKBIA—pancreatic cancer	1.5e-05	0.000155	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.49e-05	0.000154	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NOTCH1—pancreatic cancer	1.48e-05	0.000154	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—KRAS—pancreatic cancer	1.47e-05	0.000152	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CB—pancreatic cancer	1.45e-05	0.000151	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CG—pancreatic cancer	1.45e-05	0.000151	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—NRAS—pancreatic cancer	1.45e-05	0.000151	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EGF—pancreatic cancer	1.43e-05	0.000149	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCL8—pancreatic cancer	1.4e-05	0.000145	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CA—pancreatic cancer	1.35e-05	0.00014	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TERT—pancreatic cancer	1.33e-05	0.000138	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—EGFR—pancreatic cancer	1.32e-05	0.000137	CbGpPWpGaD
Adenosine—ADK—Metabolism—AKT1—pancreatic cancer	1.31e-05	0.000136	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CB—pancreatic cancer	1.31e-05	0.000136	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CD—pancreatic cancer	1.27e-05	0.000132	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HIF1A—pancreatic cancer	1.27e-05	0.000132	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TSC2—pancreatic cancer	1.27e-05	0.000132	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.26e-05	0.000131	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL8—pancreatic cancer	1.26e-05	0.00013	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—KRAS—pancreatic cancer	1.25e-05	0.00013	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—HRAS—pancreatic cancer	1.25e-05	0.00013	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APOE—pancreatic cancer	1.24e-05	0.000129	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KDR—pancreatic cancer	1.22e-05	0.000126	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—AKT1—pancreatic cancer	1.21e-05	0.000126	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CASP3—pancreatic cancer	1.2e-05	0.000125	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCND1—pancreatic cancer	1.17e-05	0.000121	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CTNNB1—pancreatic cancer	1.16e-05	0.00012	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NFKBIA—pancreatic cancer	1.16e-05	0.00012	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.15e-05	0.000119	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOTCH1—pancreatic cancer	1.14e-05	0.000119	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MMP9—pancreatic cancer	1.14e-05	0.000118	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTEN—pancreatic cancer	1.13e-05	0.000117	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CG—pancreatic cancer	1.12e-05	0.000116	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—NRAS—pancreatic cancer	1.12e-05	0.000116	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CB—pancreatic cancer	1.11e-05	0.000115	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EGF—pancreatic cancer	1.11e-05	0.000115	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—AKT1—pancreatic cancer	1.1e-05	0.000114	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CA—pancreatic cancer	1.09e-05	0.000113	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL8—pancreatic cancer	1.07e-05	0.000111	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—HRAS—pancreatic cancer	1.06e-05	0.00011	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SRC—pancreatic cancer	1.05e-05	0.000109	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—AKT1—pancreatic cancer	1.03e-05	0.000107	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CASP3—pancreatic cancer	1.02e-05	0.000106	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—EGFR—pancreatic cancer	1.02e-05	0.000106	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—VEGFA—pancreatic cancer	1.02e-05	0.000106	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—STAT3—pancreatic cancer	1.01e-05	0.000105	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NRAS—pancreatic cancer	1.01e-05	0.000105	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCND1—pancreatic cancer	9.95e-06	0.000103	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CTNNB1—pancreatic cancer	9.85e-06	0.000102	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CD—pancreatic cancer	9.84e-06	0.000102	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	9.75e-06	0.000101	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MMP9—pancreatic cancer	9.66e-06	0.0001	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—KRAS—pancreatic cancer	9.64e-06	0.0001	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTEN—pancreatic cancer	9.6e-06	9.97e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MYC—pancreatic cancer	9.38e-06	9.74e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AKT1—pancreatic cancer	9.37e-06	9.73e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TGFB1—pancreatic cancer	9.36e-06	9.72e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EGFR—pancreatic cancer	9.18e-06	9.53e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SRC—pancreatic cancer	8.9e-06	9.24e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—AKT1—pancreatic cancer	8.9e-06	9.24e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	8.85e-06	9.19e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—VEGFA—pancreatic cancer	8.67e-06	9e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KRAS—pancreatic cancer	8.67e-06	9e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—STAT3—pancreatic cancer	8.59e-06	8.92e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CB—pancreatic cancer	8.58e-06	8.91e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NRAS—pancreatic cancer	8.57e-06	8.89e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL8—pancreatic cancer	8.24e-06	8.56e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HRAS—pancreatic cancer	8.19e-06	8.5e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MYC—pancreatic cancer	7.98e-06	8.28e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CA—pancreatic cancer	7.97e-06	8.27e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AKT1—pancreatic cancer	7.96e-06	8.27e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TGFB1—pancreatic cancer	7.96e-06	8.26e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CASP3—pancreatic cancer	7.89e-06	8.19e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EGFR—pancreatic cancer	7.8e-06	8.1e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TP53—pancreatic cancer	7.71e-06	8e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCND1—pancreatic cancer	7.68e-06	7.97e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CTNNB1—pancreatic cancer	7.61e-06	7.9e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MMP9—pancreatic cancer	7.46e-06	7.74e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTEN—pancreatic cancer	7.41e-06	7.7e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KRAS—pancreatic cancer	7.37e-06	7.65e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HRAS—pancreatic cancer	7.37e-06	7.65e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKT1—pancreatic cancer	7.23e-06	7.51e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SRC—pancreatic cancer	6.87e-06	7.14e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CA—pancreatic cancer	6.77e-06	7.03e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—VEGFA—pancreatic cancer	6.7e-06	6.95e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—STAT3—pancreatic cancer	6.63e-06	6.88e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NRAS—pancreatic cancer	6.61e-06	6.87e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TP53—pancreatic cancer	6.55e-06	6.8e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKT1—pancreatic cancer	6.51e-06	6.76e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HRAS—pancreatic cancer	6.27e-06	6.51e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MYC—pancreatic cancer	6.16e-06	6.4e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TGFB1—pancreatic cancer	6.15e-06	6.38e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EGFR—pancreatic cancer	6.03e-06	6.26e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KRAS—pancreatic cancer	5.69e-06	5.91e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKT1—pancreatic cancer	5.53e-06	5.74e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CA—pancreatic cancer	5.23e-06	5.43e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TP53—pancreatic cancer	5.06e-06	5.25e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HRAS—pancreatic cancer	4.84e-06	5.02e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKT1—pancreatic cancer	4.27e-06	4.44e-05	CbGpPWpGaD
